Oct 19, 2026 08:01AM
Oct 6, 2026 08:01AM
Oct 6, 2026 08:00AM
Aug 12, 2026 04:01PM
May 11, 2026 04:01PM
May 7, 2026 08:04AM
May 7, 2026 08:00AM ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
Mar 17, 2026 05:00PM
Mar 5, 2026 04:01PM
Dec 22, 2025 08:00AM
Dec 22, 2025 08:00AM
Nov 10, 2025 08:00AM
Sep 9, 2025 08:00AM
Sep 9, 2025 08:00AM Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer
Aug 11, 2025 08:00AM
Jul 21, 2025 08:01AM
Jul 21, 2025 08:00AM
May 14, 2025 07:52AM
May 12, 2025 08:00AM
Mar 7, 2025 06:42AM
Mar 3, 2025 07:00AM ArriVent BioPharma Reports Full Year 2024 Financial Results
Nov 14, 2024 08:00AM
Sep 9, 2024 12:07PM
Sep 9, 2024 12:05PM
Mar 28, 2024 08:30PM
Mar 28, 2024 04:05PM
Jan 5, 2024 04:20PM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All